Previous Article | Next Article 
Journal of Virology, April 1999, p. 3102-3107, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Simian Virus 40 Small-t and Large-T Antigens
Jointly Regulate Cell Cycle Reentry in Human Fibroblasts
Analía
Porrás,
Stéphanie
Gaillard, and
Kathleen
Rundell*
Department of Microbiology-Immunology and
Robert H. Lurie Comprehensive Cancer Center, Northwestern
University, Chicago, Illinois 60611
Received 25 September 1998/Accepted 15 December 1998
 |
ABSTRACT |
Focus formation in human diploid fibroblasts (HDF cells) is known
to require both the simian virus 40 (SV40) large-T and small-t antigens. Similarly, both SV40 proteins were required to stimulate confluent, density-arrested HDF cells to reenter the cell cycle. This
study used defective recombinant adenoviruses to examine the roles of
the individual SV40 proteins in altering specific steps in the cell
cycle. Small-t antigen and, to a lesser extent, large-T antigen
increased the level of the S phase cyclin cyclin A but without
increasing the activity of associated cyclin kinases unless the two
SV40 proteins were coexpressed. The absence of kinase activity
reflected the presence in density-arrested cells of high levels of the
cyclin-dependent kinase inhibitors p21WAF1 and
p27KIP1. We report here that expression of SV40 large-T
antigen reduced levels of p21WAF1, while expression of
small-t antigen was required to decrease p27KIP1. The
separate effects of large-T and small-t antigens on these two
inhibitors may explain the joint requirement for the two proteins to
drive cell cycle reentry of HDF cells and ultimately transform these cells.
 |
INTRODUCTION |
Cellular transformation by simian
virus 40 (SV40) is influenced by two viral early proteins, the large-T
and small-t antigens (1, 10, 16, 26). Large-T is a key
transforming protein that functions through its binding of the cellular
tumor suppressors p53 and pRb (13). A DnaJ-like domain is
located in the amino-terminal sequences shared by large-T and small-t
(11), and this also plays a role in several transformation
systems and in the targeting of p107 and p130, pRb family members, for
degradation (29-31, 37).
Small-t antigen is necessary for large-T to transform some cell types
to anchorage-independent growth (1, 10, 16), and also for
focus formation in some established rodent cells (38) and in
primary human diploid fibroblasts (HDF cells) (21, 24). The
ability of small-t to bind and inhibit protein phosphatase 2A (PP2A)
correlates with its ability to enhance transformation by large-T in
these systems. Interestingly, small-t can also complement at least two
amino-terminal mutations in large-T antigen, allowing focus formation
in HDF cells (21). The mechanism for this complementation is
presently unknown.
In animal models, the role for small-t antigen has been most apparent
in nondividing tissues. Transgenic animals or animals injected with
SV40 mutant viruses that lack small-t antigen develop tumors in rapidly
dividing tissues, but the absence of small-t strongly reduces the
appearance of other types of tumors (2, 3). Along these
lines, studies of Chinese hamster lung cells in tissue culture showed
that a few cell divisions could replace the need for small-t antigen in
anchorage-independent growth assays (14). Experiments like
these have reinforced the basic theme that the primary role for small-t
antigen in transformation is in the induction of growth of target cells
and that the efficiency of transformation by large-T is increased in
these cells.
Because of the apparent role for small-t in nondividing target cells
and because the earliest steps in the process of cell transformation
involve the stimulation of cell cycle progression, it was important to
determine the exact effects of small-t or large-T expression in
regulating activities that control the cell cycle in normal cells. In
this study, HDF cells were used as a model of density-dependent growth
arrest. We report here that both small-t and large-T antigens are
required to induce cell cycle reentry and that this reflects the
reduction in levels of separate cyclin-dependent kinase inhibitors
(CKIs) by the viral proteins.
 |
MATERIALS AND METHODS |
Cell culture.
Fibroblasts were isolated from newborn-human
foreskins by trypsin digestion to separate the dermal and epidermal
layers, followed by collagenase treatment to release fibroblasts from
the dermal layer. Cells were plated and grown in Dulbecco modified
Eagle medium containing 10% fetal bovine serum (FBS). Helper 293 cells were grown in Dulbecco modified Eagle medium plus 10% FBS and used to
grow recombinant adenoviruses as previously described (9,
21).
Western blotting.
Cells were washed twice with ice-cold
phosphate-buffered saline (PBS), scraped in a volume of 1 ml PBS, and
collected by centrifugation in a microcentrifuge. Cells were lysed with
cold lysis buffer (50 mM Tris [pH 7.4], 200 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1 mM dithiothreitol [DTT], 2% glycerol, 0.5% Nonidet P-40)
containing protease and phosphatase inhibitors (0.5 mM
phenylmethylsulfonyl fluoride; 10 µg each of leupeptin, pepstatin,
and aprotinin per ml; 1 mM NaF; and 1 mM sodium orthovanadate). Lysed
cells were vortexed for 15 s and then held on ice for 10 to 15 min
with periodic vortexing before removal of insoluble material by
centrifugation. Protein concentrations were determined by the Bio-Rad
method, and then equal amounts of total protein were loaded onto sodium dodecyl sulfate (SDS)-polyacrylamide gels (11a), separated
by electrophoresis, and transferred to Immobilon membranes (Millipore) with a buffer containing 15% methanol, 0.08% SDS, and 1× Laemmli buffer (11a) lacking SDS. After incubation with appropriate
primary and secondary antibodies, proteins were visualized by using
enhanced chemiluminescence reagents (Pierce Chemical).
The antibodies used were as follows: for cyclin A, rabbit polyclonal
immunoglobulin G anti-cyclin A H-432 (sc-751; Santa Cruz); for p27,
mouse monoclonal anti-p27 (K25020; Transduction Laboratories); and for
p21, mouse anti-human p21 (15091A; Pharmingen). Medium from the
hybridoma cell line that produces monoclonal antibody PAb419
(6) was used to detect small-t antigen.
Immunoprecipitation kinase assays.
Cells were extracted in
cold lysis buffer, and then 100 to 200 µg of each extract was
incubated with 15 µg of anti-cyclin A. Immunoprecipitates were
collected on prewashed protein A/G agarose beads (Santa Cruz) and
washed twice in lysis buffer and twice in kinase buffer (50 mM HEPES
[pH 7.4], 10 mM MgCl2, 10 mM MnCl2, 1 mM
DTT). Immunoprecipitates were resuspended in 40 µl of kinase buffer
containing 1 µg of histone H1 and 15 µCi of [
-32P]ATP (3,000 Ci/mmol; Amersham) and then incubated
at 37°C for 20 to 30 min. Reactions were stopped by the addition of
SDS sample buffer, and then the mixtures were boiled for 5 min.
Quantitation was done by densitometric analysis on a Molecular Dynamics
Personal Densitometer SI or by phosphorimaging.
In vitro degradation of p27.
Subconfluent HDF cells or
infected (40-h) confluent cultures were extracted by suspension of
PBS-washed cells in cold distilled water, followed by vortexing and one
freeze-thaw cycle. Soluble extract protein (40 µg) was then incubated
with bacterially expressed and purified His6-p27 for 6 and
9 h as described previously (18). Briefly, degradation
mixtures contained 10 mM Tris-HCl (pH 8.3), 10 mM MgCl2, 4 mM DTT, 2 mM ATP, 20 µM phosphocreatine, 80 µg of creatine
phosphokinase per ml, and 0.1% bovine serum albumin. The plasmid that
expressed recombinant p27 was provided by J. Massague (19,
20). Levels of p27 were determined by Western blot analysis.
Cell cycle analysis by flow cytometry.
Cells were removed
from 6-cm-diameter tissue culture plates by trypsinization and pelleted
by centrifugation for 10 min at 2,000 rpm in a tabletop IEC centrifuge.
Recovered cells were lysed and stained in a solution containing 4 mM
sodium citrate (pH 7.8), 100 µg of propidium iodide per ml, 0.5 mg of
RNase per ml, 0.1% Triton X-100, and 3% polyethylene glycol 8000. After 20 min at 37°C, an equal volume of hypertonic salt solution
(0.35 M sodium chloride, 100 µg of propidium iodide per ml, 0.1%
Triton X-100, and 3% polyethylene glycol 8000) was added. Stained
nuclei were held overnight at 4°C, passed through nylon filters, and
then analyzed on a Becton Dickinson Flow Cytometer with Cell-Quest software.
 |
RESULTS |
We have shown previously that focus formation by HDF cells
requires both the SV40 large-T and small-t antigens (21).
Focus formation is an assay in which transformed cells must overcome density arrest (contact inhibition) and overgrow cell monolayers. HDF
cells are particularly susceptible to density-dependent growth arrest,
and they fail to reenter the cell cycle even in response to addition of
fresh medium and serum (24, 36). Figure
1 compares the cell cycle progression of
serum-arrested subconfluent (Fig. 1A) and confluent (Fig. 1B) cultures
of HDF cells. Readdition of serum to subconfluent cultures resulted in
significant levels of S and G2/M phase cells by 24 h.
In the experiment shown here, over 60% of the cells had DNA contents
beyond diploid by this time. These cells divided and returned to
G1 phase by 30 to 34 h after serum addition. In
contrast, fewer than 15% of the confluent cells entered S or
G2/M following serum addition, and these few did so at a
lower rate. Entry into S or G2/M was not simply delayed in
these cultures, and incubation for longer periods of time did not
increase the numbers of cells that left G1.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Cell cycle progression in confluent and subconfluent HDF
cells. (A) Confluent plates of HDF cells were subcultured 1:6 and then
placed in serum-free medium for 48 h. Medium containing 10% FBS
was added to the arrested cells, which were harvested by trypsinization
16, 24, 30, and 34 h later. Cells were collected by
centrifugation, fixed, and stained for flow cytometry as described in
Materials and Methods. (B) Confluent plates of HDF cells were placed in
serum-free medium for 48 h and then stimulated with medium
containing 10% FBS. Cells were collected and stained at the same times
as shown for panel A.
|
|
In an effort to mimic the ability of transformed cells to overgrow cell
monolayers, we first asked whether both SV40 proteins were required for
the induction of cell cycle progression in confluent, density-arrested
HDF cells. Recombinant adenoviruses that express the individual SV40
protein were used, because these allow efficient expression of
recombinant proteins by entire cultures of cells in short periods of
time. These viruses, Ad-LT and Ad-st, have been used in previous
studies (9, 33) and express either large-T or small-t
antigen, respectively, from the cytomegalovirus (CMV) promoter inserted
in place of the adenovirus E1 A/B genes. HDF cells were grown to
confluence, held in medium with reduced serum for 48 h, and then
infected with 20 PFU of Ad-LT or Ad-st per cell singly or in
combination. As shown in Fig. 2, only
cells that were coinfected with Ad-LT and Ad-st were able to progress through the cell cycle to the S and G2/M stages.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 2.
Induction of cell cycle progression by large-T plus
small-t antigens. Confluent monolayers of HDF cells were placed in
serum-free medium for 48 h and then infected with 20 PFU of Ad-CMV
(A), Ad-LT (B), or Ad-ST (C) per cell or coinfected with 20 PFU each of
Ad-ST and Ad-LT per cell (D). Medium removed from cells at the
beginning of the infection was replaced after the 1-h infection period.
At 32 h postinfection, cells were harvested, fixed, and stained
for flow cytometry as described in Materials and Methods.
|
|
Early studies identified the cyclin A promoter as one target of the
transactivating function of small-t antigen (21).
Consequently, we examined the ability of the individual viral proteins
to increase levels of cyclin A in confluent HDF cells. As shown in Fig.
3A, levels of cyclin A protein increased
in cells infected with either Ad-LT or Ad-st, and small-t was more
effective than large-T in this regard. The two proteins acted
synergistically, and coinfection with Ad-LT and Ad-st led to dramatic
increases in the levels of cyclin A protein. Cells at confluence
expressed cyclin E, and no changes in the levels of cyclin E were found
in these experiments (data not shown).

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 3.
Induction of cyclin A and cyclin A-associated kinase
activity by SV40 tumor antigens. Confluent monolayers of HDF cells were
stimulated with medium containing 10% FBS or infected with Ad-CMV
(CMV), Ad-LT (LT), Ad-ST (ST), or a combination of Ad-ST and Ad-LT
(LT/ST) as described for Fig. 2. At 27 h postinfection, cells were
extracted with buffer containing 0.5% Nonidet P-40 and protease and
phosphatase inhibitors. (A) Equal amounts of each extract were used for
Western blot analysis of cyclin A (Cyc A). (B and C) Equal portions of
each extract were used for immunoprecipitation with anti-cyclin A
antibodies, and then immunoprecipitated proteins were assayed for
kinase activity with histone H1 and [32P]ATP as
substrates.
|
|
Cyclin A-associated kinase activity was also measured by
immunoprecipitation-kinase assay with histone H1 as a substrate (Fig. 3B). Coinfection with the two viruses stimulated high levels of the
kinase activity. Surprisingly, when compared to control infections (Ad-CMV), small-t was unable to activate cyclin A-associated kinase activity, even though its expression led to substantially increased cyclin A levels. Ad-LT also failed to activate cyclin A-associated kinase activity, but this was less surprising given the smaller amounts
of cyclin A protein present in Ad-LT-infected cells. Finally, addition
of fresh serum to confluent HDF cells failed to activate cyclin
A-associated kinase activity (Fig. 3C), a finding that was consistent
with the inability of serum to induce cell cycle progression in these cells.
The absence of detectable cyclin A-associated kinase activity in Ad-LT-
or Ad-st-infected cells, as well as in serum-stimulated cells,
suggested that one or more CKIs might be present in these cells.
Accordingly, extracts were tested for the presence of several CKIs,
results for two of which are shown here. The first,
p21WAF1, also known as p21CIP1, is known to be
present in confluent cells and is particularly responsive to
transcriptional induction by p53 (4, 5, 7, 35). As shown in
Fig. 4A, p21 was present at high levels
in confluent HDF cells, and levels of this inhibitor were reduced when
cells were infected for 28 h with the Ad-LT, but not the Ad-st,
virus. Serum addition was also able to decrease p21 levels.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of large-T and small-t antigens on cyclin
inhibitors p21WAF1 and p27KIP1. Confluent
monolayers of HDF cells were serum stimulated or infected as described
for Fig. 2 and 3. The experiments shown in the three panels were
performed at different times. (A) Cells were extracted at 27 h
postinfection, and then 50 µg of protein from each extract was used
for Western blot analysis of the CKI p21WAF1. (B) Cells
were extracted at 20, 28, and 34 h postinfection, and then
extracts were analyzed for p27KIP1 as for panel A. (C)
Cells were treated with serum or infected for 32 h and then were
extracted for p27KIP1 analysis.
|
|
The second CKI studied was p27KIP1, an inhibitor that is
particularly important in contact inhibition (19). Levels of
p27 were high in confluent cells and decreased only in Ad-st- or doubly infected cultures (Fig. 4B and C). Expression of small-t alone was
sufficient to decrease levels of p27, but coexpression of both large-T
and small-t antigens resulted in a more rapid decline in the levels of
this inhibitor (Fig. 4B).
In an effort to determine the mechanism through which small-t antigen
reduced p27 levels, degradation of His6-tagged p27 was monitored in vitro. One of the best-known mechanisms for regulating p27
levels occurs at the level of protein stability. As reported by others
(18), extracts from subconfluent, cycling cells promoted the
degradation of the recombinant p27 molecule (Fig.
5). A prominent degradation fragment was
apparent after incubation for 6 or 9 h, and the total level of p27
was reduced. Extracts from density-arrested cells had no effect on p27
levels in the same time periods. Under the conditions used here,
small-t did not appear to promote the degradation of p27, at least in
vitro.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
Failure of infected-cell extracts to degrade p27 in
vitro. Confluent cultures of HDF cells were infected with Ad-LT plus
Ad-ST for 40 h, and then cell extracts made with water were used
to assay cell-free degradation of recombinant p27. Negative controls in
this experiment were Ad-CMV-infected or uninfected (MOCK) confluent
cultures, while extracts of subconfluent cells (SUBCONF) were used as a
positive control. Levels of p27 were determined by Western blot
analysis, following incubation periods of 0, 6 or 9 h under the
conditions described in Materials and Methods.
|
|
In summary, both large-T expression and fresh serum addition decreased
the levels of p21, while small-t antigen expression alone could trigger
a decline in p27. Assuming that the joint role for large-T and small-t
in cell cycle reentry reflects a requirement for reduction of the
levels of both inhibitors, we predicted that the expression of small-t
antigen (but not of large-T antigen) in the presence of serum should
also allow cell cycle progression. This was, in fact, found to be the
case (Fig. 6). When confluent cells were
infected with 20 PFU of Ad-st per cell and then placed in medium
containing 10% serum, significant numbers of cells left G1
and accumulated in the G2/M stage of the cell cycle (Fig.
6C). Nearly 75% of all cells could be driven into the cell cycle when
cells were infected with higher multiplicities of Ad-st or with both
Ad-st and Ad-LT in the presence of serum (data not shown). Cells
infected with Ad-LT were completely unable to reenter the cell cycle,
even in the presence of fresh serum (Fig. 6D). The failure of large-T
and serum to cooperate in growth induction was of interest because we
had observed previously that LT by itself was unable to cause focus
formation in HDF cells, even when high serum levels were maintained
throughout the 4- to 6-week assay period (data not shown). This
reinforces the concept that small-t would be needed for regulation of
the CKI p27 for cell growth and eventual focus formation to occur.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 6.
Induction of HDF cell cycle progression by small-t
antigen in the presence of serum. Confluent monolayers of HDF cells
were infected with Ad-ST or the small-t mutant virus Ad-C103S and then
fed with fresh medium containing 10% FBS at the end of the infection
period. Cells were harvested, fixed, and stained for
fluorescence-activated cell sorter analysis at 32 h postinfection.
The patterns shown are for serum-stimulated cells (A), cells infected
with Ad-ST in the absence of serum (B), cells infected with Ad-ST in
the presence of 10% serum (C), and cells infected with Ad-LT in the
presence of 10% serum (D).
|
|
 |
DISCUSSION |
The first step in the process of transformation of growth-arrested
cells is reentry into the growth cycle. The results presented here
argue that, for many cells types, the combined action of CKIs may block
cell cycle progression, thus requiring more than a single stimulus for
a response. In the case of SV40, the joint requirement for small-t and
large-T antigens may be explained by their independent actions on the
inhibitors p21WAF1 and p27KIP1. In HDF cells, a
system in which both viral proteins are required for focus formation,
large-T antigen expression decreases p21 levels while small-t antigen
expression decreases p27 levels. HDF cells are particularly sensitive
to density arrest and are not readily stimulated at confluence to
undergo even a single round of cell cycling. This behavior contrasts
with that of many established rodent cell lines, in which density
arrest occurs but is easily overridden by the addition of medium
containing fresh serum. The fact that SV40 large-T antigen is often
sufficient to cause focus formation in such established rodent cells
may reflect this less tight regulation of growth and confluence. It may
be that p27 plays a less significant role in density-dependent growth
arrest of cell lines that respond both to serum and to large-T antigen alone.
The regulation of p27 levels by small-t may also play a role in other
small-t-dependent systems. Small-t-dependent focus formation has also
been observed in mouse 10T1/2 cells (18a, 30, 38), rat 3Y1
cells (32), and rat embryo fibroblasts (38).
Several cell lines for which small-t is not required in focus formation do depend on small-t for anchorage-independent growth (1, 14, 23). It is interesting that the cell cycle arrest that occurs when normally adherent cells are placed under nonadherent conditions involves the inhibitors p21 and p27 (17). This suggests that reductions of p21 by large-T and of p27 by small-t could account for
the need for both of these proteins for SV40 to induce
anchorage-independent growth in relevant target cells.
The mechanism through which large-T causes a decline in p21 levels may
well involve its binding of the tumor suppressor protein p53. The
expression of p21 is known to reflect levels of p53 present in cells,
and in fact, one of the ways in which p21 was first identified was as a
p53-responsive gene (5). Formal proof of this possibility
will require the study of large-T mutants with reduced or no binding to
p53. Assuming that this is the case, it seems unlikely that large-T
regulation of p21 levels is a key feature of the transforming activity
of large-T. Binding of large-T antigen to p53 is often not required for
transformation or tumorigenesis, although p53 binding plays a
significant role in protecting cells from apoptosis (15, 22, 27,
30). Also, in the HDF focus formation assay, it is unlikely that
large-T is required to regulate p21 protein levels, at least in the
first few days of the assay, because 10% serum is present during this
initial period until cells achieve confluence (21).
The mechanism through which small-t affects levels of p27 is completely
unknown. Much of the regulation of p27 is believed to be at either the
translational (8) or the posttranslational (18,
25) level. The half-life of p27 is reduced in subconfluent cells
relative to density-arrested ones, and this can be demonstrated by
using cell extracts (18). Although we were able to reproduce this finding for subconfluent cells, extracts from cells expressing small-t did not promote p27 degradation, and consequently, other mechanisms through which small-t might function will need to be explored. For example, small-t might affect the translational efficiency of the p27 message or the efficiency of its transcription, a
possibility suggested by the known ability of small-t to function as a
transcriptional regulator (12, 21, 34). It may also be the
case that small-t will promote p27 degradation, but with reaction
requirements that have not yet been duplicated in cell extracts.
The reduction of p27 levels by small-t is a novel addition to the known
activities of small-t antigen that contribute to the enhancement of
transformation by SV40. Earlier studies showed that the binding and
inhibition of PP2A was essential in this regard (16, 21),
and this is likely to reflect the activation of key cellular enzymes
such as MEK, MAPK (9, 28), and the Na/H antiporter
(9). It will be interesting to determine whether the
reduction in p27 levels is completely separate from these other
functions of small-t. The recent demonstration that the half-life of
p27 was influenced by its phosphorylation (25) suggests a
possible connection between PP2A inhibition and p27 stability, a
potential mechanism that is currently being tested in this laboratory.
 |
ACKNOWLEDGMENTS |
This work was supported by NIH grant R01 CA21327 to K.R. We are
grateful for assistance in the purchase of new laboratory equipment
from funds of the Lester G. Woods Foundation, administered by the
Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology-Immunology and The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 303 E. Chicago Ave., Chicago, IL
60611. Phone: (312) 503-5917. Fax: (312) 908-1372. E-mail: krundell{at}nwu.edu.
 |
REFERENCES |
| 1.
|
Bouck, N.,
N. Beales,
T. Shenk,
P. Berg, and G. di Mayorca.
1978.
New region of the simian virus 40 genome required for efficient viral transformation.
Proc. Natl. Acad. Sci. USA
75:2473-2477[Abstract/Free Full Text].
|
| 2.
|
Carbone, M.,
A. M. Lewis,
B. J. Matthews,
A. S. Levine, and K. Dixon.
1989.
Characterization of hamster tumors induced by simian virus 40 small t deletion mutants as true histiocytic lymphomas.
Cancer Res.
49:1565-1571[Abstract/Free Full Text].
|
| 3.
|
Choi, Y.,
I. Lee, and S. R. Ross.
1988.
Requirement for the simian virus 40 small t antigen in tumorigenesis in transgenic mice.
Mol. Cell. Biol.
8:3382-3390[Abstract/Free Full Text].
|
| 4.
|
Dulic, V.,
W. K. Kaufmann,
S. J. Wilson,
T. D. Tlsty,
E. Lees,
J. W. Harper,
S. J. Elledge, and S. I. Reed.
1994.
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.
Cell
76:1013-1023[Medline].
|
| 5.
|
El-Deiry, W. S.,
T. Tokino,
V. E. Velculescu,
D. B. Levy,
R. Parson,
J. M. Trent,
D. Lin,
W. E. Mercer,
K. W. Kinzler, and B. Vogelstein.
1993.
WAF1, a potential mediator of p53 tumor suppression.
Cell
75:817-825[Medline].
|
| 6.
|
Harlow, E.,
L. V. Crawford,
D. C. Pim, and N. M. Williamson.
1981.
Monoclonal antibodies specific for simian virus 40 tumor antigens.
J. Virol.
39:861-869[Abstract/Free Full Text].
|
| 7.
|
Harper, J. W.,
G. R. Adami,
N. Wei,
K. Keyomarski, and S. J. Elledge.
1993.
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Cell
75:805-816[Medline].
|
| 8.
|
Hengst, L., and S. I. Reed.
1996.
Translational control of p27Kip1 accumulation during the cell cycle.
Science
271:1861-1864[Abstract].
|
| 9.
|
Howe, A. K.,
S. Gaillard,
J. S. Bennett, and K. Rundell.
1998.
Cell cycle progression in monkey cells expressing simian virus 40 small t antigen from adenovirus vectors.
J. Virol.
72:9637-9644[Abstract/Free Full Text].
|
| 10.
|
Jog, P.,
B. Joshi,
V. Dhamankar,
M. J. Imperiale,
J. Rutila, and K. Rundell.
1990.
Mutational analysis of simian virus 40 small t antigen.
J. Virol.
64:2895-2900[Abstract/Free Full Text].
|
| 11.
|
Kelley, W. L., and S. J. Landry.
1994.
Chaperone power in a virus?
Trends Biochem. Sci.
19:2767-2768.
|
| 11a.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 12.
|
Loeken, M.,
I. Bikel,
D. M. Livingston, and J. Brady.
1988.
Trans-activation of RNA polymerase II and III promoters by SV40 small t antigen.
Cell
55:1171-1177[Medline].
|
| 13.
|
Manfredi, J. J., and C. Prives.
1994.
The transforming activity of simian virus 40 large tumor antigen.
Biochim. Biophys. Acta
1198:65-83[Medline].
|
| 14.
|
Martin, R.,
V. Setlow,
C. Edwards, and D. Vembu.
1979.
The roles of the simian virus 40 tumor antigens in transformation of Chinese hamster lung cells.
Cell
17:635-643[Medline].
|
| 15.
|
McCarthy, S. A.,
H. S. Symonds, and T. Van Dyke.
1994.
Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53.
Proc. Natl. Acad. Sci. USA
91:3979-3983[Abstract/Free Full Text].
|
| 16.
|
Mungre, S.,
K. Enderle,
B. Turk,
A. Porras,
Y.-Q. Wu,
M. C. Mumby, and K. Rundell.
1994.
Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small-t antigen in vitro decrease viral transformation.
J. Virol.
68:1675-1681[Abstract/Free Full Text].
|
| 17.
|
Orend, G.,
T. Hunter, and E. Ruoslahti.
1998.
Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Oncogene
16:2575-2583[Medline].
|
| 18.
|
Pagano, M.,
S. W. Tam,
A. M. Theodoras,
P. Beer-Romero,
G. Del Sal,
V. Chau,
P. R. Yew,
G. F. Draetta, and M. Rolfe.
1995.
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
Science
269:682-685[Abstract/Free Full Text].
|
| 18a.
| Phillips, B., and K. Rundell. Unpublished data.
|
| 19.
|
Polyak, K.,
J. Kato,
M. J. Solomon,
C. J. Sherr,
J. Massague,
J. M. Roberts, and A. Koff.
1994.
p27Kip1, a cyclin-cdk inhibitor, links transforming growth factor- and contact inhibition to cell cycle arrest.
Genes Dev.
8:9-22[Abstract/Free Full Text].
|
| 20.
|
Polyak, K.,
M.-H. Lee,
H. Erdjument-Bromage,
A. Koff,
J. Roberts,
P. Tempst, and J. Massague.
1994.
Cloning of p27 Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
Cell
78:59-66[Medline].
|
| 21.
|
Porras, A.,
J. Bennett,
A. Howe,
K. Tokos,
N. Bouck,
B. Henglein,
S. Sathyamangalam,
B. Thimmapaya, and K. Rundell.
1996.
A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assays.
J. Virol.
70:6902-6908[Abstract/Free Full Text].
|
| 22.
|
Quartin, R. S.,
C. N. Cole,
J. M. Pipas, and A. J. Levine.
1994.
The amino-terminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53 mediated growth arrest of cells.
J. Virol.
68:1334-1341[Abstract/Free Full Text].
|
| 23.
|
Rubin, H.,
J. Figge,
M. T. Bladon,
L. B. Chen,
M. Ellman,
I. Bikel,
M. Farrell, and D. M. Livingston.
1982.
Role of small t antigen in the acute transforming activity of SV40.
Cell
30:469-480[Medline].
|
| 24.
|
Rundell, K.,
S. Gaillard, and A. Porras.
1998.
Small-t and large-T antigens cooperate to drive cell proliferation.
Dev. Biol. Stand.
94:127-133[Medline].
|
| 25.
|
Sheaff, R. J.,
M. Groudine,
M. Gordon,
J. M. Roberts, and B. E. Clurman.
1997.
Cyclin E-CDK2 is a regulator of p27Kip1.
Genes Dev.
11:1464-1478[Abstract/Free Full Text].
|
| 26.
|
Sleigh, M.,
W. Topp,
R. Hanich, and J. Sambrook.
1978.
Mutants of SV40 with an altered small t protein are reduced in their ability to transform cells.
Cell
14:79-88[Medline].
|
| 27.
|
Sompayrac, L., and K. J. Danna.
1991.
The amino-terminal 147 amino acids of SV40 large T antigen transform secondary rat embryo fibroblasts.
Virology
181:412-415[Medline].
|
| 28.
|
Sontag, E.,
S. Fedorov,
C. Kamibayashi,
D. Robbins,
M. Cobb, and M. Mumby.
1993.
The interaction of SV40 small t antigen with protein phosphatase 2A stimulates the Map kinase pathway and induces cell proliferation.
Cell
75:887-897[Medline].
|
| 29.
|
Srinivasan, A.,
A. J. McClellan,
J. Vartikar,
I. Marks,
P. Cantalupo,
Y. Li,
P. Whyte,
K. Rundell,
J. L. Brodsky, and J. M. Pipas.
1997.
The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain.
Mol. Cell. Biol.
17:4761-4773[Abstract].
|
| 30.
|
Srinivasan, A.,
K. W. C. Peden, and J. M. Pipas.
1989.
The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions.
J. Virol.
63:5459-5463[Abstract/Free Full Text].
|
| 31.
|
Stubdal, H.,
J. Zalvide,
K. S. Campbell,
C. Schweitzer,
T. M. Roberts, and J. A. DeCaprio.
1997.
Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen.
Mol. Cell. Biol.
17:4979-4990[Abstract].
|
| 32.
|
Sugano, S.,
N. Yamaguchi, and H. Shimojo.
1982.
Small t protein of simian virus 40 is required for dense focus formation in a rat cell line.
J. Virol.
41:1073-1076[Abstract/Free Full Text].
|
| 33.
|
Swaminathan, S., and B. Thimmapaya.
1996.
Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome.
J. Mol. Biol.
258:736-746[Medline].
|
| 34.
|
Wang, W.-B.,
I. Bikel,
E. Marsilio,
D. Newsome, and D. M. Livingston.
1994.
Transrepression of RNA polymerase II promoters by the simian virus 40 small t antigen.
J. Virol.
68:6180-6187[Abstract/Free Full Text].
|
| 35.
|
Xiong, Y.,
G. J. Hannon,
H. Zhang,
D. Casso,
R. Kobayashi, and D. Beach.
1993.
p21 is a universal inhibitor of cyclin kinases.
Nature
366:701-704[Medline].
|
| 36.
|
Yoshizumi, M.,
C.-M. Hsieh,
F. Zhou,
J.-C. Tsai,
C. Patterson,
M. A. Perrella, and M.-E. Lee.
1995.
The ATF site mediates downregulation of the cyclin A gene during contact inhibition in vascular endothelial cells.
Mol. Cell. Biol.
15:3266-3272[Abstract].
|
| 37.
|
Zalvide, J.,
H. Stubdal, and J. A. DeCaprio.
1998.
The J domain of simian virus 40 large T antigen is required to functionally inactivate RB family members.
Mol. Cell. Biol.
18:1408-1415[Abstract/Free Full Text].
|
| 38.
|
Zhu, J.,
P. W. Rice,
L. Gorsch,
M. Abate, and C. N. Cole.
1992.
Transformation of a continuous rat embryo fibroblast cell line requires three separate domains of simian virus 40 large T antigen.
J. Virol.
66:2780-2791[Abstract/Free Full Text].
|
Journal of Virology, April 1999, p. 3102-3107, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Van Vleet, T. R., Watterson, T. L., Klein, P. J., Coulombe, R. A. Jr.
(2006). Aflatoxin B1 Alters the Expression of p53 in Cytochrome P450-Expressing Human Lung Cells. Toxicol Sci
89: 399-407
[Abstract]
[Full Text]
-
Shaffer, D. R., Viale, A., Ishiwata, R., Leversha, M., Olgac, S., Manova, K., Satagopan, J., Scher, H., Koff, A.
(2005). Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate. Proc. Natl. Acad. Sci. USA
102: 210-215
[Abstract]
[Full Text]
-
Moreno, C. S., Ramachandran, S., Ashby, D. G., Laycock, N., Plattner, C. A., Chen, W., Hahn, W. C., Pallas, D. C.
(2004). Signaling and Transcriptional Changes Critical for Transformation of Human Cells by Simian Virus 40 Small Tumor Antigen or Protein Phosphatase 2A B56{gamma} Knockdown. Cancer Res.
64: 6978-6988
[Abstract]
[Full Text]
-
Shaikh, S., Skoczylas, C., Longnecker, R., Rundell, K.
(2004). Inability of Simian Virus 40 To Establish Productive Infection of Lymphoblastic Cell Lines. J. Virol.
78: 4917-4920
[Abstract]
[Full Text]
-
Johannessen, M., Olsen, P. A., Sorensen, R., Johansen, B., Seternes, O. M., Moens, U.
(2003). A role of the TATA box and the general co-activator hTAFII130/135 in promoter-specific trans-activation by simian virus 40 small t antigen. J. Gen. Virol.
84: 1887-1897
[Abstract]
[Full Text]
-
Garcea, R. L., Imperiale, M. J.
(2003). Simian Virus 40 Infection of Humans. J. Virol.
77: 5039-5045
[Full Text]
-
Yuan, H., Veldman, T., Rundell, K., Schlegel, R.
(2002). Simian Virus 40 Small Tumor Antigen Activates AKT and Telomerase and Induces Anchorage-Independent Growth of Human Epithelial Cells. J. Virol.
76: 10685-10691
[Abstract]
[Full Text]
-
Sullivan, C. S., Pipas, J. M.
(2002). T Antigens of Simian Virus 40: Molecular Chaperones for Viral Replication and Tumorigenesis. Microbiol. Mol. Biol. Rev.
66: 179-202
[Abstract]
[Full Text]
-
Budinger, G. R. S., Tso, M., McClintock, D. S., Dean, D. A., Sznajder, J. I., Chandel, N. S.
(2002). Hyperoxia-induced Apoptosis Does Not Require Mitochondrial Reactive Oxygen Species and Is Regulated by Bcl-2 Proteins. J. Biol. Chem.
277: 15654-15660
[Abstract]
[Full Text]
-
Gaillard, S., Fahrbach, K. M., Parkati, R., Rundell, K.
(2001). Overexpression of Simian Virus 40 Small-T Antigen Blocks Centrosome Function and Mitotic Progression in Human Fibroblasts. J. Virol.
75: 9799-9807
[Abstract]
[Full Text]
-
Gjoerup, O., Zaveri, D., Roberts, T. M.
(2001). Induction of p53-Independent Apoptosis by Simian Virus 40 Small t Antigen. J. Virol.
75: 9142-9155
[Abstract]
[Full Text]
-
Schuchner, S., Nemethova, M., Belisova, A., Klucky, B., Holnthoner, W., Wintersberger, E.
(2001). Transactivation of Murine Cyclin A by Polyomavirus Large and Small T Antigens. J. Virol.
75: 6498-6507
[Abstract]
[Full Text]
-
Fux, C., Moser, S., Schlatter, S., Rimann, M., Bailey, J. E., Fussenegger, M.
(2001). Streptogramin- and tetracycline-responsive dual regulated expression of p27Kip1 sense and antisense enables positive and negative growth control of Chinese hamster ovary cells. Nucleic Acids Res
29: e19-e19
[Abstract]
[Full Text]
-
Gjoerup, O., Chao, H., DeCaprio, J. A., Roberts, T. M.
(2000). pRB-Dependent, J Domain-Independent Function of Simian Virus 40 Large T Antigen in Override of p53 Growth Suppression. J. Virol.
74: 864-874
[Abstract]
[Full Text]
-
Waheed, I., Guo, Z. S., Chen, G. A., Weiser, T. S., Nguyen, D. M., Schrump, D. S.
(1999). Antisense to SV40 Early Gene Region Induces Growth Arrest and Apoptosis in T-Antigen-positive Human Pleural Mesothelioma Cells. Cancer Res.
59: 6068-6073
[Abstract]
[Full Text]
-
Schuchner, S., Wintersberger, E.
(1999). Binding of Polyomavirus Small T Antigen to Protein Phosphatase 2A Is Required for Elimination of p27 and Support of S-Phase Induction in Concert with Large T Antigen. J. Virol.
73: 9266-9273
[Abstract]
[Full Text]